Partners
Working with the crème de la crème of medicine and tech
We work with top pharma, frontier tech, leading hospitals, and world-class clinicians.
Numbers that matter
Data Partners
The world’s largest patient data network
K Pro learns from real patient data: histology, omics, imaging and clinical outcomes, followed over time. Every dataset is curated to be AI-ready, so K Pro can turn it into new biology, biomarkers and treatment hypotheses.
pharma Partners
Trusted by the world's largest pharma
The world's largest pharmaceutical companies have licensed K Pro, our AI Scientist, to accelerate their R&D, putting AI agents to work on target discovery, biomarkers, competitive intelligence and clinical development.
Technology Partners
Built with leaders in AI, data and compute
We partner with leading technology companies so K Pro is powered by the best data, runs on secure infrastructure, and works with the tools your teams already use.
Driving value for our hospital partners
Owkin and Hôpital Foch collaborate to test and validate biomarkers identified by Owkin's AI (through K Pro) on human tumour samples, enabling Hôpital Foch to contribute to the development of more personalized medicine.
The program maps multimodal data across 11 therapeutic areas in Owkin's extensive transatlantic network, bringing together 20 leading healthcare institutions across France, Germany, Israel, Italy, Spain, the UK, and the US, enhancing their AI expertise.
Owkin and University Hospital Vienna collaborate to advance cancer research and patient outcomes with the deployment of K Pro, Owkin’s AI copilot for biology. Hospital Vienna is pioneering agentic AI to ultimately improve outcomes for cancer patients.
Owkin and Newcastle upon Tyne Hospitals NHS Foundation Trust have entered a five-year partnership to explore how agentic AI can help advance drug discovery, development, and diagnostics - improving their foundation for AI led products.
KOLs
Built in collaboration with the world's leading researchers and clinicians
AI in medicine has to earn clinicians' trust. A network of 150 key opinion leaders works with us to sharpen K Pro, grow our data network and co-author the research that proves what it can do.
“To implement AI in something as important as clinical research we need to take time to validate its utility at each step.”
“For the MOSAIC project with Owkin, we have this incredible opportunity to develop a dataset that’s going to be transformative, I think, in cancer.”
Put the AI Scientist to work on your questions
Join the pharma companies already using K Pro, or bring your data, technology or expertise to the network.
Owkin maximizes the value of your data and makes it actionable for AI.